John Willis
Internal Medicine · Columbus, OHNPI 1467550095
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,551 and has fallen 96.2% since, to $59 in 2022.
Across 147 payments — averaging $14.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$357
- Amarin Pharma, Inc.$229
- AstraZeneca$207
- GSK$187
- Johnson & Johnson$161
- Portola Pharmaceuticals, LLC$112
- plus $845 from 16 others
What the payments were for
- Food & beverage$2,07499%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $357 |
| Amarin Pharma, Inc. | 15 | $229 |
| AstraZeneca | 10 | $207 |
| GSK | 17 | $187 |
| Johnson & Johnson | 12 | $161 |
| Portola Pharmaceuticals, LLC | 1 | $112 |
| Lilly USA, LLC | 9 | $111 |
| Amgen | 6 | $92 |
| Avanir Pharmaceuticals, Inc. | 5 | $84 |
| Pfizer | 5 | $78 |
| Sanofi-aventis U.S. LLC | 5 | $78 |
| Astellas Pharma US Inc | 5 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $67 |
| Boehringer Ingelheim | 5 | $66 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Merck | 2 | $29 |
| Novartis | 2 | $29 |
| Genentech USA, Inc. | 2 | $27 |
| Metuchen Pharmaceuticals | 1 | $15 |
| Medtronic | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$112
How this compares
$2,098 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 12 | $325 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Columbus
- Raghu KolluriColumbus$89K
- Youssef YoussefColumbus$59K
- Abdullah KhanColumbus$58K
- Benjamin BuckColumbus$35K
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.